Board
Screen
Heat
Cal
Watch
News
Blog
TV
Home
/
IOVA
Home
/
IOVA

NASDAQ
$8.7
$8.7

Overview

Price performance
Low
$8.47
High
$9.09
After hours. Last updated: Nov 4, 2026, 9:00 PM UTC
$
8.70
-0.13 (-1.47%)
Average, 50 days
$11.38
$5.90
Open
$8.87
Previous close
$8.83
52-week high
$15.37
Oct 21, 2026 (15 days ago)
52-week low
$1.76
Nov 5, 2025 (13 months ago)
394.32%

Valuation & Estimates

Earnings

Financials

Insider Trading

Peer Analysis

Insights & Activity

Market Cap
3.94B
Volume
17 254 109
Total Return (3M)
99.54%
Total Return (1Y)
378.02%
16.73
Sector
Healthcare
Links
Tags
Healthcare
Biotechnology
NASDAQ
US
Website
iovance.com
About
Iovance Biotherapeutics, Inc., a biotechnology firm currently in the clinical development stage, is committed to discovering and bringing to market cancer immunotherapy solutions. Its core mission involves leveraging the patient's own immune system to effectively combat and eradicate cancerous cells. The company is presently conducting six Phase 2 clinical trials. These include study C-144-01, evaluating its primary experimental compound, lifileucel, for individuals with advanced melanoma. Another trial, C-145-04, is assessing lifileucel's potential for treating cervical cancer that is recurrent, metastatic, or persistent. Additionally, investigational product LN-145 is undergoing evaluation in trial C-145-03 for recurrent and/or metastatic head and neck squamous cell carcinoma. Iovance Biotherapeutics, Inc. maintains strategic alliances and licensing arrangements with several distinguished entities, including H. Lee Moffitt Cancer Center, M.D. Anderson Cancer Center, Ohio State University, the Centre hospitalier de l'Université de Montreal, Cellectis S.A., and Novartis Pharma AG. Established in 2007, the company was previously known as Lion Biotechnologies, Inc. It adopted its current name, Iovance Biotherapeutics, Inc., in June 2017. Its corporate offices are located in San Carlos, California.

Frequently asked questions

IOVA · Iovance Biotherapeutics, Inc.

01What is Iovance Biotherapeutics, Inc. stock price today?

The current price of IOVA is $8.70 — it has decreased by 1.47% since the previous close. Data as of Nov 4, 2026.

02Is Iovance Biotherapeutics, Inc. stock price growing?

IOVA is down 4.71% over the past week, down 38.82% over the past month and up 378.02% over the past year. The price is above its 200-day moving average of $5.90.

03What do analysts say about IOVA stock?

Of the 9 analysts covering Iovance Biotherapeutics, Inc., 2 rate it a strong buy, 5 rate it a buy and 2 rate it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.

04What is Iovance Biotherapeutics, Inc. market cap?

Iovance Biotherapeutics, Inc. has a market capitalization of $3.94B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

05Does Iovance Biotherapeutics, Inc. pay dividends?

Iovance Biotherapeutics, Inc. has not paid any dividends over the past year.

06How volatile is IOVA stock?

In the latest trading session IOVA moved between $8.47 and $9.09, a range of 7.13% of its current price.

07What are IOVA stock 52-week high and low?

Over the past 52 weeks IOVA has traded between $1.76 and $15.37. The current price is 43.40% below its 52-week high.

Figures as of Nov 4, 2026. This information is provided for general purposes only and is not investment advice.